Claudio Bertuccioli

Title: Innovations and Contributions of Claudio Bertuccioli

Introduction

Claudio Bertuccioli is a notable inventor based in New York, NY, with a significant contribution to the field of biotechnology. He holds four patents that reflect his innovative work in developing proteins and polypeptides for medical applications, particularly in vaccine development.

Latest Patents

One of his latest patents is focused on conformationally stabilized respiratory syncytial virus (RSV) pre-fusion F proteins. This invention provides RSV F proteins, polypeptides, and protein complexes that include cross-links to stabilize the protein in its pre-fusion conformation. Additionally, it offers compositions that comprise these proteins, including vaccine formulations and methods for their use. Another significant patent involves influenza hemagglutinin proteins, which are engineered to maintain their native trimeric conformation even when the head domain is disrupted. This invention also includes compositions for use as vaccine immunogens.

Career Highlights

Claudio has worked with prominent organizations such as Calder Biosciences Inc. and the National Institutes of Health, which is a component of the US Department of Health & Human Services. His work in these institutions has allowed him to contribute to important advancements in health and medicine.

Collaborations

Throughout his career, Claudio has collaborated with notable professionals, including Peter Joseph Alff and Christopher P. Marshall. These collaborations have further enhanced his research and development efforts in the field.

Conclusion

Claudio Bertuccioli's innovative work in biotechnology, particularly in the development of proteins for vaccines, showcases his significant contributions to medical science. His patents reflect a commitment to advancing health solutions through scientific research and collaboration.